Trevor Allred
Stock Analyst at Oppenheimer
(2.87)
# 1,553
Out of 5,097 analysts
5
Total ratings
88.89%
Success rate
40.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Trevor Allred
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TBPH Theravance Biopharma | Initiates: Outperform | $27 | $18.79 | +43.69% | 1 | Dec 3, 2025 | |
| MBX MBX Biosciences | Maintains: Outperform | $38 → $80 | $30.42 | +162.98% | 2 | Sep 23, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Outperform | $85 | $99.73 | -14.77% | 1 | Sep 9, 2025 | |
| INVA Innoviva | Initiates: Outperform | $35 | $19.99 | +75.09% | 1 | Aug 11, 2025 |
Theravance Biopharma
Dec 3, 2025
Initiates: Outperform
Price Target: $27
Current: $18.79
Upside: +43.69%
MBX Biosciences
Sep 23, 2025
Maintains: Outperform
Price Target: $38 → $80
Current: $30.42
Upside: +162.98%
Palvella Therapeutics
Sep 9, 2025
Initiates: Outperform
Price Target: $85
Current: $99.73
Upside: -14.77%
Innoviva
Aug 11, 2025
Initiates: Outperform
Price Target: $35
Current: $19.99
Upside: +75.09%